FDA.reportPublic FDA data

dalbavancin

RxCUI
1539239
RxNorm name
dalbavancin
Term type
IN
Status
Active
Updated
2026-06-04 07:08:23

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
072014
Active start
072014
Multiple ingredient
NO
Branded
NO

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRdalbavancin1NAMES
RxNorm Namedalbavancin1NAMES
TTYIN1ATTRIBUTES
SPL_SET_ID
5 linked values
5CODES
UNII_CODE808UI9MS5K1CODES
RxCUI15392391CODES
MMSL_CODE
2 linked values
2CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 2 matching rows.

UNII, Preferred term, Registry number table
UNIIPreferred termRegistry numberSource
808UI9MS5KDALBAVANCIN171500-79-1tbl_unii_list
808UI9MS5KDALBAVANCIN171500-79-1tbl_unii_list

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DalbavancinDALBAVANCINSomerset Therapeutics, LLCf4c0bd0f-03c2-4ce5-bcc2-b58f21ce75c12026-07-28Warnings, Adverse reactionsName fallback
generic name: DALBAVANCIN
DalbavancinDALBAVANCINBE Pharmaceuticals Inc.6c188995-ab05-45c3-a3af-5b1bcd655fdc2026-06-12Warnings, Adverse reactionsName fallback
generic name: DALBAVANCIN
DalbavancinDALBAVANCINMeitheal Pharmaceuticals Inc966995bb-9d92-434d-b75a-1786072b81c92025-12-03Warnings, Adverse reactionsName fallback
generic name: DALBAVANCIN
DalbavancinDALBAVANCINTeva Pharmaceuticals, Inc.1f4a5924-96d7-445a-b75f-2c0e1ffd2dea2025-10-06Warnings, Adverse reactionsName fallback
generic name: DALBAVANCIN
DALVANCEDALBAVANCINAllergan, Inc.4b4674d8-4d1e-4728-8465-d42ada33fa5c2025-01-13Warnings, Adverse reactionsName fallback
generic name: DALBAVANCIN

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCJ01XAGlycopeptide antibacterialsATC1-4dalbavancin
FDASPLD000077427LipoglycopeptidesCHEMhas_chemical_structuredalbavancin
FDASPLN0000191281Lipoglycopeptide AntibacterialEPChas_epcdalbavancin
MEDRTD017334TeicoplaninCHEMhas_ingredientdalbavancin
MEDRTD004342Drug HypersensitivityDISEASEci_withdalbavancin
MEDRTD004342Drug HypersensitivityDISEASEci_withdalbavancin hydrochloride
MEDRTD012874Skin Diseases, InfectiousDISEASEmay_treatdalbavancin
MEDRTD012874Skin Diseases, InfectiousDISEASEmay_treatdalbavancin hydrochloride
MEDRTD013203Staphylococcal InfectionsDISEASEmay_treatdalbavancin
MEDRTD013203Staphylococcal InfectionsDISEASEmay_treatdalbavancin hydrochloride
MEDRTD013290Streptococcal InfectionsDISEASEmay_treatdalbavancin
MEDRTD013290Streptococcal InfectionsDISEASEmay_treatdalbavancin hydrochloride
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moadalbavancin
MEDRTN0000000150Protein Synthesis InhibitorsMOAhas_moadalbavancin hydrochloride
MEDRTN0000008479Decreased Cell Wall Synthesis & RepairPEhas_pedalbavancin
MEDRTN0000008479Decreased Cell Wall Synthesis & RepairPEhas_pedalbavancin hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESRXNAV_HUMAN_DRUGUS
CODESATCJ01XA04
CODESDRUGBANKDB06219
CODESSNOMEDCT703917001
CODESSNOMEDCT703919003
CODESVUID4025243
SOURCESSourceAnatomical Therapeutic Chemical
SOURCESSourceDrug Bank
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File